Intestinal Permeability and Its Regulation by Zonulin: Diagnostic and Therapeutic Implications

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 10, 2012, Pages 1096-1100

  Fasano, Alessio ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune Disease; Bacterial Overgrowth; Gluten; Gut Inflammation; Obesity

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GLIADIN; HAPTOGLOBIN; LARAZOTIDE; MYELOID DIFFERENTIATION FACTOR 88; UNCLASSIFIED DRUG; ZONULIN;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; DIAGNOSTIC VALUE; ENTERITIS; GENETIC SUSCEPTIBILITY; HUMAN; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SMALL INTESTINE MUCOSA; TIGHT JUNCTION; TRANSLATION REGULATION; UPREGULATION;

CHOLERA TOXIN; GASTROINTESTINAL DISEASES; HUMANS; IMMUNE SYSTEM DISEASES; INTESTINAL MUCOSA; PERMEABILITY; TIGHT JUNCTIONS;

EID: 84866437998     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.08.012     Document Type: Article

References (15)

1. Fasano A., Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol 2005, 2:416-422.
2. Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev 2011, 91:151-175.
3. Tripathi A., Lammers K.M., Goldblum S., et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A 2009, 106:16799-16804.
4. El Asmar R., Panigrahi P., Bamford P., et al. Host-dependent activation of the zonulin system is involved in the impairment of the gut barrier function following bacterial colonization. Gastroenterology 2002, 123:1607-1615.
5. Lammers K.M., Lu R., Brownley J., et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008, 135:194-204.
6. Fasano A. Surprises from celiac disease. Sci Am 2009, 301:54-61.
7. de Kort S., Keszthelyi D., Masclee A.A. Leaky gut and diabetes mellitus: what is the link?. Obes Rev 2011, 12:449-458.
8. Meddings J.B., Jarand J., Urbanski S.J., et al. Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol 1999, 276:G951-G957.
9. Di Pierro M., Lu R., Uzzau S., et al. Zonula occludens toxin structure-function analysis: identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J Biol Chem 2001, 276:19160-19165.
10. Watts T., Berti I., Sapone A., et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A 2005, 102:2916-2921.
11. Sapone A., de Magistris L., Pietzak M., et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006, 55:1443-1449.
12. Simpson M., Mojibian M., Barriga K., et al. An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus. Pediatr Diabetes 2009, 10:563-572.
13. Moreno-Navarrete J.M., Sabater M., Ortega F., et al. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One 2012, 7:e37160.
14. Paterson B.M., Lammers K.M., Arrieta M.C., et al. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Aliment Pharmacol Ther 2007, 26:757-766.
15. Leffler D.A., Kelly C.P., Abdallah H.Z., et al. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol 2012 July 24, Epub ahead of print.